Kresken Michael, Grabein Béatrice, Becker Karsten, Straube Eberhard, Wichelhaus Thomas A, Willinger Birgit
Antiinfectives Intelligence GmbH, Campus Hochschule Bonn-Rhein-Sieg, Rheinbach, Germany.
Rheinische Fachhochschule Köln gGmbH, Cologne, Germany.
GMS Infect Dis. 2020 Mar 26;8:Doc18. doi: 10.3205/id000062. eCollection 2020.
This is the second chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2 updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Preliminary microbiological findings regarding the patient and their immediate environment are crucial for the calculation of treatment with antibiotics in each case, as well as the resistance situation of the ward on which the patient is being cared for. If such data is not available, regional or supra-regional data can be used as a fallback. This chapter describes the methods of susceptibility testing, informs about the resistance situation in Germany and describes the main resistance mechanisms of bacterial pathogens against antibiotics. Further, the chapter informs about collateral damage of antibiotics as well as medical measures against increasing resistance.
这是《成人细菌性感染的初始肠外计算治疗指南 - 2018年更新》第二版第二章。保罗·埃利希化疗协会(PEG)的德国指南已被翻译,以面向国际受众。关于患者及其直接环境的初步微生物学检查结果对于每种情况下抗生素治疗的计算至关重要,患者所在病房的耐药情况也是如此。如果没有此类数据,可以使用区域或超区域数据作为替代。本章介绍了药敏试验方法,通报了德国的耐药情况,并描述了细菌病原体对抗生素的主要耐药机制。此外,本章还介绍了抗生素的附带损害以及应对耐药性增加的医疗措施。